Inventor · disambiguated record
Ivars Kalvinsh
Also filed as: KALVINSH IVARS · KALVINSH IVARS Y
38 granted patents·17 pending applications·674 citations·filing 1982–2015
98Inventor score
Files withMERZ PHARMA GMBH & CO KGAA16TOPOTARGET UK LTD11INST ORGANICHESKOGO SINTEZA AK3KALVINSH IVARS3MERZ & CO GMBH & CO3
Top patents by PatentIndex Score
55 records- 0196US6034134A1-Amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Mar 7, 2000·238 cites·22 claims
- 0293US6888027B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted May 3, 2005·65 cites·63 claims
- 0392US7557140B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2008·Granted Jul 7, 2009·19 cites·24 claims
- 0492US7407988B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2006·Granted Aug 5, 2008·17 cites·22 claims
- 0591US6960685B2Carbamic acid compounds comprising an ether linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted Nov 1, 2005·66 cites·69 claims
- 0688US7183298B2Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Feb 27, 2007·27 cites·124 claims
- 0784US6071966A1-amino-alkylcyclohexane NMDA receptor antagonistsMERZ & CO GMBH & CO·Filed 1998·Granted Jun 6, 2000·74 cites·12 claims
- 0883US7981895B2Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2008·Granted Jul 19, 2011·6 cites·64 claims
- 0982US7880020B2Carbamic acid compounds comprising an amide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2009·Granted Feb 1, 2011·5 cites·49 claims
- 1080US7985753B2Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted Jul 26, 2011·6 cites·19 claims
- 1179US7569724B2Carbamic acid compounds comprising an amide linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2001·Granted Aug 4, 2009·12 cites·93 claims
- 1279US4481218A3-(2,2,2-Trimethylhydrazinium)propionate and method for the preparation and use thereofINST ORGANICHESKOGO SINTEZA AK·Filed 1982·Granted Nov 6, 1984·31 cites·6 claims
- 1378US6828462B2Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2002·Granted Dec 7, 2004·14 cites·9 claims
- 1470US7629343B2Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2003·Granted Dec 8, 2009·4 cites·86 claims
- 1569US7947689B2Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Granted May 24, 2011·1 cites·19 claims
- 1668US7652036B2Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Jan 26, 2010·4 cites·38 claims
- 1767US7598384B2Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Oct 6, 2009·1 cites·77 claims
- 1866US6602862B11-Amino-alkylcyclohexanes as trypanocidal agentsMERZ PHARMA GMBH & CO KGAA·Filed 2000·Granted Aug 5, 2003·3 cites·16 claims
- 1964US7223797B2Meldonium salts, method of their preparation and pharmaceutical composition on their basisGRINDEKS JSC·Filed 2004·Granted May 29, 2007·5 cites·14 claims
- 2062US7022729B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2003·Granted Apr 4, 2006·1 cites·3 claims
- 2161US5776935APyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmissionMERZ & CO GMBH & CO·Filed 1996·Granted Jul 7, 1998·22 cites·12 claims
- 2261US5017611AEthyl-3-(2-ethyl-2,2-dimethylhydrazinium)-propionate salts to treat arrhythmiaBREMANIS GUNAR A·Filed 1989·Granted May 21, 1991·10 cites·2 claims
- 2361US4451485ATreatment of cardio-vascular diseases with 3-(2,2,2-trimethylhydrazinium) propionate dihydrateINSTITU ORCH SINTEZA AKADEMII·Filed 1982·Granted May 29, 1984·10 cites·4 claims
- 2461US2009227582A1Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2009·Application pending·0 cites
- 2560US7465719B2Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitorsTOPOTARGET UK LTD·Filed 2004·Granted Dec 16, 2008·2 cites·53 claims
- 2659US5965615AHydroxyl radical scavengerTAIHO PHARMACEUTICAL CO LTD·Filed 1996·Granted Oct 12, 1999·17 cites·4 claims
- 2757US8071620B2Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitorsFINN PAUL W·Filed 2009·Granted Dec 6, 2011·0 cites·27 claims
- 2856US2007185151A1Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 2956US2005107445A1Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitorsPROLIFIX LTD·Filed 2004·Application pending·0 cites
- 3055US7238703B2Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jul 3, 2007·0 cites·3 claims
- 3153US7550482B2Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Jun 23, 2009·0 cites·11 claims
- 3253US2007105961A11-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2006·Application pending·0 cites
- 3351US7700576B2Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldoniumLATVIAN INST OF ORGANIC SYNTHE·Filed 2006·Granted Apr 20, 2010·1 cites·17 claims
- 3451US4633014ASubstituted 3-hydrazinopropionatesINST ORGANICHESKOGO SINTEZA AK·Filed 1984·Granted Dec 30, 1986·6 cites·4 claims
- 3550US2011275810A1Carbamic acid compounds comprising a piperazine linkage as hdac inhibitorsWATKINS CLARE J·Filed 2011·Application pending·0 cites
- 3647US2011212956A1Pyrazolopyrimidines for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2011·Application pending·0 cites
- 3747US2011105572A1Carbamic acid compounds comprising an amide linkage as hdac inhibitorsWATKINS CLARE J·Filed 2011·Application pending·0 cites
- 3846US2010311741A1Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic AgentsINHIBOX LTD·Filed 2008·Application pending·0 cites
- 3945US2007299113A1Metabotropic glutamate receptor modulatorsMERZ PHARMA GMBH & CO KGAA·Filed 2007·Application pending·0 cites
- 4045US2011028438A1Medical use of 3-2,2,2-trimethylhydrazinium propionate salts.JSC GRINDEKS·Filed 2008·Application pending·0 cites
- 4144US9102615B2N-Carbamoylmethy1-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical useVEINBERG GRIGORY·Filed 2007·Granted Aug 11, 2015·0 cites·6 claims
- 4243US4686215APharmaceutical composition and method for treating tumors susceptible to 2-carbamoylaziridineINST ORGANICHESKOGO SINTEZA AK·Filed 1985·Granted Aug 11, 1987·2 cites·13 claims
- 4343US2010298442A11-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonistsMERZ PHARMA GMBH & CO KGAA·Filed 2010·Application pending·0 cites
- 4442US2006004001A1Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptorsMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 4541US5859056APharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium)propionate and γ-butyrobetaineFiled 1996·Granted Jan 12, 1999·4 cites·11 claims
- 4638US2006074083A1Cyclic and acyclic propenones for treating CNS disordersMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 4737US2010029646A1Prodrugs of diphenyl ox-indol-2-one compoundsTOPOTARGET AS·Filed 2007·Application pending·0 cites
- 4836US2004242590A1Pharmaceutical composition comprising gamma-butyrobetaineFiled 2002·Application pending·0 cites
- 4933US9382203B2N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical useJOINT STOCK COMPANY JSC “OLAINFARM”·Filed 2015·Granted Jul 5, 2016·0 cites·4 claims
- 5030US8492413B2Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancerDUBURS GUNARS·Filed 2010·Granted Jul 23, 2013·0 cites·11 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ivars Kalvinsh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →